Discontinuation of Reversible Long-Acting Contraceptive and Associated Factors among Female Users in Health Facilities of Hawassa City, Southern Ethiopia: Cross-Sectional Study

References

• Alemayehu M, Belachew T, Tilahun T. Factors associated with utilization of long acting and permanent contraceptive methods among married women of reproductive age in Mekelle town, Tigray region, north Ethiopia. BMC Pregnancy Childbirth. 2012;12(1):6. doi:10.1186/1471-2393-12-6
   PubMed Web of Science ®Google Scholar
• Ali MM, Park MH, Ngo TD. Levels and determinants of switching following intrauterine device discontinuation in 14 developing countries. Contraception. 2014;90(1):47–53. doi:10.1016/j.contraception.2014.03.008
   Web of Science ®Google Scholar
• Ali MM, Sadler RK, Cleland J, Ngo TD, Shah IH. Long-Term Contraceptive Protection Discontinuation and Switching Behaviour. Intrauterine Device (IUD) Use Dynamics in 14 Developing Countries. London: World Health Organization and Marie Stopes International; 2011.
   Google Scholar
• Balogun O, Olaomo N, Adeniran A, Fawole A. Implanon sub-dermal implant: an emerging method of contraception in Ilorin, Nigeria. J Med Biomed Sci. 2014;3(1):1–5. doi:10.4314/jmbs.v3i1.1
   Google Scholar
• Bhatia P, Nangia S, Aggarwal S, Tewari C. Implanon: subdermal single rod contraceptive implant. J Obstet Gynaecol India. 2011;61(4):422. doi:10.1007/s13224-011-0066-z
   PubMedGoogle Scholar
• Birhane K, Hagos S, Fantahun M. Early discontinuation of implanon and its associated factors among women who ever used implanon in Ofla District, Tigray, Northern Ethiopia. Int J Pharm Sci Rev. 2015;6(3):544–551.
   Google Scholar
• Blumenthal P, Voedisch A, Gemzell-Danielsson K. Strategies to prevent unintended pregnancy: increasing use of long-acting reversible contraception. Hum Reprod Update. 2010;17(1):121–137. doi:10.1093/humupd/dmq026
   Web of Science ®Google Scholar
• Bradley SE, Schwandt H, Khan S. Levels, trends, and reasons for contraceptive discontinuation. DHS Anal Stud. 2009;20.
   Google Scholar
• Burusie A. Reasons for premature removal of implanon among users in Arsi Zone, Oromia Region, Ethiopia. Reprod Syst Sex Disorders. 2015;4(1).
   Google Scholar
• Casey PM, Long ME, Marnach ML, Bury JE. Bleeding related to etonogestrel subdermal implant in a US population. Contraception. 2011;83(5):426–430. doi:10.1016/j.contraception.2010.09.012
   PubMed Web of Science ®Google Scholar
• CSA. Population and housing census of Ethiopia 2017. Available from: https://unstats.un.org/unsd/censuskb20/Attachment489.aspx?AttachmentType=1. Accessed August 7, 2020.
   Google Scholar
• Gebremedhin S. Trend and socio-demographic differentials of Caesarean section rate in Addis Ababa, Ethiopia: analysis based on Ethiopia demographic and health surveys data. Reprod Health. 2014;11(1):14. doi:10.1186/1742-4755-11-14
   PubMed Web of Science ®Google Scholar
• Harvey C, Seib C, Lucke J. Continuation rates and reasons for removal among Implanon® users accessing two family planning clinics in Queensland, Australia. Contraception. 2009;80(6):527–532. doi:10.1016/j.contraception.2009.05.132
   PubMed Web of Science ®Google Scholar
• Igwe N. Intrauterine contraceptive device use in Abakaliki, southeast Nigeria: a 5-year review. Trop J Med Res. 2016;19(2):138. doi:10.4103/1119-0388.185441
   Google Scholar
• Mahumud RA, Hossain MG, Sarker AR, et al. Prevalence and associated factors of contraceptive discontinuation and switching among Bangladeshi married women of reproductive age. Open Access J Contracep. 2015;6:13.
   Google Scholar
• Melkamu Asaye M, Syoum Nigussie T, Mequannt Ambaw W. Early Implanon Discontinuation and Associated Factors among Implanon User Women in Debre Tabor Town, Public Health Facilities, Northwest Ethiopia, 2016. Int J Reprod Med. 2018;2018:1–10. doi:10.1155/2018/3597487
   Google Scholar
• Muthir J, Nyango D. Indications for removal of etonogestrel implant within two years of use in Jos, Nigeria. East Afr Med J. 2010;87(11).
   Google Scholar
• Ott MA, Sucato GS. Contraception for adolescents. Pediatrics. 2014;2014–2300.
   Google Scholar
• Rademacher KH, Vahdat HL, Dorflinger L, Owen DH, Steiner MJ. Global introduction of a low-cost contraceptive implant. In: Kulczycki A, editor. Critical Issues in Reproductive Health. Netherlands: Springer; 2014:285–306.
   Google Scholar
• RamaRao S, Lacuesta M, Costello M, Pangolibay B, Jones H. The link between quality of care and contraceptive use. Int Fam Plan Perspect. 2003;29(2):76–83. doi:10.2307/3181061
   PubMedGoogle Scholar
• Staveteig S, Mallick L, Winter R. Uptake and Discontinuation of Long-Acting Reversible Contraceptives (LARCS) in Low-Income Countries. ICF International; 2015.
   Google Scholar
• Tadesse A, Kondale M, Agedew E, Gebremeskel F, Boti N, Oumer B. Determinant of implanon discontinuation among women who ever used implanon in Diguna Fango District, Wolayita Zone, Southern Ethiopia: a community based case control study. Int J Reprod Med. 2017;2017.
   Google Scholar
• Teunissen AM, Grimm B, Roumen FJ. Continuation rates of the subdermal contraceptive Implanon® and associated influencing factors. Eur J Contracept Reprod Health Care. 2014;19(1):15–21. doi:10.3109/13625187.2013.862231
   PubMed Web of Science ®Google Scholar
• WHO. Causes and consequences of contraceptive discontinuation: evidence from 60 demographic and health surveys; 2012. Available from: https://www.who.int/reproductivehealth/publications/family_planning/9789241504058/en/. Accessed November 20, 2018.
   Google Scholar
• Yalew SA, Zeleke BM, Teferra AS. Demand for long acting contraceptive methods and associated factors among family planning service users, Northwest Ethiopia: a health facility based cross sectional study. BMC Res Notes. 2015;8(1):29. doi:10.1186/s13104-015-0974-6
   Google Scholar